アフターアワーズ： 3.01 -0.10 -3.22%

Evaxion Biotech A S Adr (EVAX)

Evaxion Biotech A S Adr (EVAX) 最新ニュース

Evaxion Biotech A S Adr (EVAX)

Evaxion Biotech A S Adr (EVAX) 最新ニュース

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN

Evaxion Biotech A/S ADR (EVAX) Stock: From Low to High in 52 Weeks - The InvestChronicle

EVAX’s price-to-cash ratio: Is it a good investment at the moment? - US Post News

Evaxion Biotech Partners With Merck To Expand Vaccine Development - Benzinga

Evaxion Biotech inks vaccine licensing deal with MSD - Investing.com

Evaxion stock jumps on expanded vaccine development pact with MSD (NASDAQ:EVAX) - Seeking Alpha

H.C. Wainwright keeps buy rating on Evaxion stock, cites promising AI-powered cancer vaccine - Investing.com

Evaxion Biotech enhances AI vaccine discovery platform - Investing.com

Evaxion Biotech enhances AI vaccine discovery platform - Investing.com India

Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction - GlobeNewswire Inc.

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN

Evaxion reports promising phase 2 trial results for cancer vaccine - Investing.com

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - MSN

Evaxion reports high response rate in melanoma trial - Investing.com

Evaxion reports breakthrough in gonorrhea vaccine research - Investing.com

Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2 - GlobeNewswire Inc.

European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading - MSN

European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading - MSN

European Equities Traded in the US as American Depositary Receipts Edge Lower Friday; Set to End Week Up 0.5% - MSN

European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading - MSN

Earnings call: Evaxion Biotech reports Q2 results, optimistic on EVX-01 - Investing.com India

Earnings call: Evaxion Biotech reports Q2 results, optimistic on EVX-01 - Investing.com

Earnings call: Evaxion Biotech reports Q2 results, optimistic on EVX-01 - Investing.com UK

Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now - MSN

European Equities Traded in the US as American Depositary Receipts Move Lower in Tuesday Trading - MSN

European Equities Traded in the US as American Depositary Receipts Trend Lower Friday; Set to End Week Down 4% - MSN

European Equities Traded in the US as American Depositary Receipts Trend Lower Thursday - MSN

MSN - MSN

CVB Financial Corp secures key executives with new employment agreements By Investing.com - Investing.com India

Cathie Wood's ARK ETF adjusts portfolio with key stock trades on July 8 By Investing.com - Investing.com

Winmill & Co. buys shares of Bexil Investment Trust worth over $12k By Investing.com - Investing.com

Evaxion Biotech reports progress in AI-powered vaccine development By Investing.com - Investing.com UK

European Equities Traded in the US as American Depositary Receipts Lower Tuesday - MSN

European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN

Evaxion Biotech advances in personalized cancer vaccine - Investing.com India

Evaxion Biotech advances in personalized cancer vaccine By Investing.com - Investing.com India

Evaxion Biotech advances in personalized cancer vaccine By Investing.com - Investing.com

Evaxion Biotech advances in personalized cancer vaccine By Investing.com - Investing.com UK

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method - GlobeNewswire Inc.

Evaxion Biotech advances in personalized cancer vaccine - Investing.com

Evaxion (EVAX) Enrolls First Patient in Phase IIb Melanoma Study - Yahoo New Zealand News

European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading - MSN

European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher - MSN

Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN

Stocks of Evaxion Biotech A/S ADR (EVAX) are poised to climb above their peers - SETE News

Daily Progress: Evaxion Biotech A/S ADR (EVAX) Gain 8.10, Closing at 2.67 - The Dwinnex

Evaxion Biotech A/S ADR (EVAX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle

European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading - MSN

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher in Monday Trading - MSN

Evaxion reports positive results for melanoma vaccine - Investing.com India

EVAX's price-to-free cash flow ratio: How it affects investment decisions – US Post News - US Post News

Evaxion reports positive results for melanoma vaccine By Investing.com - Investing.com

Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal - GlobeNewswire Inc.

Evaxion reports positive results for melanoma vaccine - Investing.com

Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower - MSN

Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024 - GlobeNewswire Inc.

Evaxion Announces Business Update and First Quarter 2024 Financial Results - GlobeNewswire Inc.

Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024 - GlobeNewswire Inc.

Evaxion Biotech Faces Nasdaq Compliance ChallengeTipRanks.com - TipRanks

Evaxion Receives Nasdaq Notification - GlobeNewswire Inc.

Evaxion Biotech's Strategic Financial PlansTipRanks.com - TipRanks

Evaxion Biotech Advances Personalized Cancer VaccineTipRanks.com - TipRanks

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01 - GlobeNewswire Inc.

Evaxion und nicht offengelegter Kooperationspartner veröffentlichen vielversprechende Ergebnisse für EVX-B1-Impfstoff-Antigene gegen Staphylococcus aureus-Infektionen - GlobeNewswire Inc.

EVAXに似た銘柄